Aptevo Therapeutics Inc. sell WatchMen
Start price
16.11.20
/
50%
€35.20
Target price
16.11.21
-
Performance (%)
-77.34%
End price
17.11.21
€7.98
Summary
This prediction ended on 17.11.21 with a price of €7.98. The SELL prediction by WatchMen for Aptevo Therapeutics Inc. performed very well with a performance of -77.34%. WatchMen has 50% into this predictionUnfortunately, there is no listed company called Aptevo Therapeutics with the symbol APVOV. However, there is a company with the symbol APVO. Aptevo Therapeutics is a biotechnology company that focuses on the discovery, development, and commercialization of novel oncology and hematology therapeutics. The company's product portfolio includes treatments for a variety of conditions such as hemophilia, immune disorders, and cancer. Their approach involves using genetically engineered proteins to target specific diseases and their therapies have shown promising results in clinical trials.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aptevo Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.961% | -2.210% | 12.839% | 17.154% |
| iShares Nasdaq 100 | 2.626% | -1.918% | 38.498% | 45.463% |
| iShares Nikkei 225® | 0.217% | -7.216% | 19.425% | 5.076% |
| iShares S&P 500 | 1.540% | -1.858% | 27.801% | 42.583% |
According to WatchMen what are the pros and cons of Aptevo Therapeutics Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
overvalued
Very low/no dividend yield expected
very negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Little innovation
Few uniques
Dependend from some customers or products
Growths much slower than the competition
Sustainability is not important
high free float
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand
Business model of the past or high risk
Comments by WatchMen for this prediction
In the thread Aptevo Therapeutics Inc diskutieren
Sell Aptevo Therapeutics Inc.
In the thread Trading Aptevo Therapeutics Inc.
Die von WatchMen gewählte maximale Laufzeit wurde überschritten